
PRA Health Sciences, Inc. PRAH
PRA Health Sciences, Inc. ROA Ratio 2011-2026 | PRAH
Annual ROA Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.72 | 6.86 | 4.83 | 2.59 | 3.11 | 3.67 | -1.6 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.86 | -1.6 | 3.45 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-4.99 | $ 17.53 | -0.79 % | $ 540 M | ||
|
Guardant Health
GH
|
-20.67 | $ 126.07 | 5.19 % | $ 15.8 B | ||
|
Agilent Technologies
A
|
11.3 | $ 115.58 | 0.43 % | $ 35.1 B | ||
|
Interpace Biosciences
IDXG
|
72.63 | $ 1.8 | - | $ 7.96 M | ||
|
Celcuity
CELC
|
-37.95 | $ 133.75 | -0.38 % | $ 6.25 B | ||
|
Illumina
ILMN
|
-19.4 | $ 149.09 | 2.66 % | $ 23.7 B | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-189.54 | $ 7.06 | -22.5 % | $ 9.39 M | ||
|
Castle Biosciences
CSTL
|
-4.18 | $ 20.98 | 6.55 % | $ 608 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-5.17 | $ 21.93 | 1.79 % | $ 1.17 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 116.01 | 1.9 % | $ 9.57 B | ||
|
Lantheus Holdings
LNTH
|
10.49 | $ 99.5 | -0.56 % | $ 6.72 B | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
23.41 | $ 1 094.18 | -0.65 % | $ 22.6 B | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
-7.94 | $ 9.46 | 2.05 % | $ 1.21 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
8.6 | $ 19.13 | 0.47 % | $ 428 M | ||
|
Natera
NTRA
|
-39.28 | $ 202.88 | 0.98 % | $ 20 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 161.98 | 3.35 % | $ 8.03 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 429.83 | 0.17 % | $ 12.4 B | ||
|
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-51.8 | $ 3.91 | 1.43 % | $ 362 M | ||
|
Personalis
PSNL
|
-24.32 | $ 9.15 | 2.35 % | $ 817 M | ||
|
Koninklijke Philips N.V.
PHG
|
3.33 | $ 26.51 | -1.65 % | $ 25.1 B | ||
|
Senseonics Holdings
SENS
|
-54.72 | $ 6.31 | -1.87 % | $ 263 M | ||
|
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
-12.1 | $ 65.38 | 0.79 % | $ 3.91 B | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.38 | -3.64 % | $ 5.47 M | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 257.25 | -0.45 % | $ 21.4 B | ||
|
Thermo Fisher Scientific
TMO
|
6.08 | $ 450.67 | 0.56 % | $ 170 B | ||
|
Waters Corporation
WAT
|
12.66 | $ 342.25 | 1.06 % | $ 20.4 B | ||
|
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.67 | 2.97 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 9.24 | 1.09 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 193.92 | 0.54 % | $ 21.5 B |